Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)

Malmstrom A., Gronberg B. H. , Stupp R., Marosi C., Frappaz D., Schultz H. P. , ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, sa.18, 2010 (SCI İndekslerine Giren Dergi) identifier